Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: July 21, 2025
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapy.
Journal: Science translational medicine
Published: November 23, 2022
Top Ten Tips Palliative Care Clinicians Should Know About Managing Immune-Mediated Endocrine Toxicities in Cancer.
Journal: Journal of palliative medicine
Published: June 13, 2022
Guiding immunotherapy combinations: Who gets what?
Journal: Advanced drug delivery reviews
Published: May 31, 2021
Dermatologic toxicities associated with radiation therapy in women with breast cancer.
Journal: International journal of women's dermatology
Published: April 26, 2020
Endogenous Glucocorticoid Signaling Regulates CD8+ T Cell Differentiation and Development of Dysfunction in the Tumor Microenvironment.
Journal: Immunity
Published: October 04, 2019
Dermatologic conditions in women receiving systemic cancer therapy.
Journal: International journal of women's dermatology
Published: August 06, 2019
Early B cell changes predict autoimmunity following combination immune checkpoint blockade.
Journal: The Journal of clinical investigation
Published: August 08, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026